4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-007911
President and CEO sold 20,000 shares at $13.19 ($263,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-02-07 | Sale | −20,000 | $13.19 | $263,800 | 7,720,314 | D |
| Open-market sales · 20,000 sh · avg $13.19 · $263,800 | |||||||
Loading xslF345X03/doc4.xml…